Hēlo system offers minimally invasive solution for chronic venous thromboembolism
Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated.
Read original article on The Medical News →Related news
-
Researchers develop versatile genetic tool to investigate cell interactions
United Kingdom
-
Exploring the potential of immunotherapy in early-stage triple-negative breast cancer
United Kingdom
-
The Midlife Man: Why We Need to Take Men’s Health More Seriously
United States
-
New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer
United Kingdom
-
Dismissive consultations leave some autoimmune patients distressed and suicidal
United Kingdom
-
Genetic findings illuminate dental abnormalities and the evolutionary loss of teeth
United Kingdom
-
Millions get GLP-1 drugs through channels insurance records may miss
United Kingdom
-
Immunotherapy combination sets a new standard of care for extensive-stage small cell lung cancer
United Kingdom